Private Equity Firm Healthcare

WindRose Health Investors

New York, New York, United States

WindRose Health Investors makes private equity investments in businesses that operate within the services sectors of healthcare. The firm focuses on companies with profitable business models and a demonstrated ability to deliver cost-effective solutions. It manages approximately $7 billion of capital and is currently making new investments out of its seventh fund.

Focus Areas
Healthcare services, Healthcare technology (services), Value-based care (investments)
Website
windrose.com

Tracked deals

23

23 tracked deals across 2018-2026.

Recent pace

4

4 tracked deals announced in the last 12 months.

Deal mix

Recapitalization

12 recapitalization · 6 growth capital · 3 addon

WindRose Health Investors Acquisition Volume by Year

Last 8 years

Acquisition volume by year Annual acquisition counts for the last 8 years for WindRose Health Investors. 1 2018 2 2019 2 2020 5 2021 5 2022 2 2024 3 2025 ~4 est. 3 2026
Actual Full-year estimate

Supporting Data

Recent Transactions

Showing the 12 most recent of 23 tracked deals for WindRose Health Investors.

  • Buyer
    Veristat, WindRose Health Investors, LLC
    Target
    Certara's Regulatory and Medical Writing business
    Seller
    Certara, Inc.
    Type
    Buyout

    Veristat announced it has entered into a definitive agreement to acquire Certara’s Regulatory and Medical Writing business. The deal is expected to close in Q2 2026 and will add 200+ (approximately 220) medical writing and regulatory experts to expand Veristat’s regulatory writing, submission strategy, and advisory capabilities across the drug development lifecycle.

  • Buyer
    WindRose Health Investors
    Target
    Clariness, SubjectWell
    Location
    Hamburg, Germany
    Type
    Addon

    WindRose Health Investors led a transaction merging Clariness and SubjectWell into a single global patient recruitment platform that will operate under the Clariness name. The combined company brings broader geographic reach, technology and a large patient database to support clinical trials across 60+ countries and accelerate enrollment and retention for sponsors, CROs and sites.

  • Buyer
    WindRose Health Investors, Francisco Partners
    Target
    Avalon Healthcare Solutions

    WindRose Health Investors has completed a growth investment in Avalon Healthcare Solutions, a Tampa-based diagnostic intelligence and lab benefits management platform. Existing investor Francisco Partners also made an additional investment to support Avalon’s continued product development and scaling for health plan clients.

  • Buyer
    WindRose Health Investors, LLC
    Target
    Stellus Rx

    WindRose Health Investors has made a strategic growth investment in Stellus Rx, a Plano, Texas–based technology-enabled, value-based pharmacy care management platform. The undisclosed transaction will fund Stellus Rx’s expansion of clinical and operational capabilities and the scaling of its platform to serve additional patient populations nationwide.

  • Buyer
    Court Square Capital Partners, WindRose Health Investors
    Target
    Soleo Health

    Court Square Capital Partners and WindRose Health Investors announced a jointly controlled recapitalization of Soleo Health, a Frisco, Texas-based provider of specialty pharmacy and infusion services. The investment will provide capital to scale Soleo's national footprint (26 pharmacies, 30+ infusion suites) and support growth across all 50 states while partnering with the company's founders and management team.

  • Buyer
    WindRose Health Investors
    Target
    CIVIE
    Seller
    Collaborative Imaging

    WindRose Health Investors completed a strategic investment to form CIVIE, an AI-powered radiology platform built from Collaborative Imaging's technology. WindRose partnered with Collaborative Imaging's management team to acquire Ci's technology platform; the investment will support product development, sales and operations scale-up, and accelerated growth across radiology practices and hospital systems.

  • Buyer
    WindRose Health Investors
    Target
    SubjectWell

    WindRose Health Investors completed a majority growth investment in SubjectWell, the patient-access marketplace that connects motivated patients to clinical trials and treatments. Terms were not disclosed; SubjectWell's management will remain in place and as active shareholders while WindRose provides growth capital to accelerate product development, machine learning and marketplace expansion.

  • Buyer
    WindRose Health Investors, LLC
    Target
    CardioOne Inc.
    Type
    Buyout

    WindRose Health Investors has completed the acquisition of CardioOne, a physician-enablement company serving independent cardiologists, and partnered with CardioOne's executive team to provide up to $100 million of additional capital to support growth. CardioOne's existing management will remain in place and the investment will fund expansion and enhancement of its technology platform and service offerings as the company prepares for value-based care.

  • Buyer
    WindRose Health Investors, LLC, Third Wave Recovery Systems, LLC
    Target
    Third Wave Recovery Systems, LLC, SRX, LLC

    WindRose Health Investors completed a growth equity investment in Third Wave Recovery Systems (TWRx) to support the company's expansion in pharmaceutical rebate administration for hospitals, long-term care facilities, and specialty providers. In conjunction with the investment, TWRx acquired SRX, LLC — a rebate management specialist for skilled nursing and long-term care — and appointed a new executive team to lead the combined business.

  • Buyer
    WindRose Health Investors
    Target
    BPD, LLC
    Seller
    BPD founders and management team

    WindRose Health Investors, a New York-based healthcare private equity firm, has completed a strategic recapitalization investment in BPD, a Boca Raton-based provider of data-driven marketing services for hospitals and health systems. The founders and management team will continue to lead and remain significant shareholders as WindRose supports BPD's expansion of service offerings and accelerated growth.

  • Buyer
    WindRose Health Investors, LLC
    Target
    RevHealth, LLC

    WindRose Health Investors completed a recapitalization of RevHealth, a Morristown, New Jersey-based omnichannel healthcare communications agency. The investment will provide capital to support RevHealth's growth and expansion of services; founders Bruce Epstein, Bruce Medd, and Brian Wheeler will continue to lead the company and remain significant shareholders.

  • Buyer
    WindRose Health Investors, LLC, Terrapin Pharmacy
    Target
    Ganse Apothecary
    Type
    Addon

    WindRose Health Investors completed the acquisition of Ganse Apothecary and merged it with Terrapin Pharmacy, an existing WindRose portfolio company, to create a behavioral health-focused pharmacy platform in the Mid-Atlantic. The combined business expands footprint and capabilities across Pennsylvania and surrounding states, serving approximately 7,500 patients across four states; terms were not disclosed.

Related Acquisition Pages

Selling a company? Get in front of buyers like WindRose Health Investors

Turn tracked acquisition activity into an outreach-ready buyer list.